
Following a $40 million investment from The Wellcome Trust and the Bill & Melinda Gates Foundation, biopharma UK firm Kymab …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

